Your browser doesn't support javascript.
loading
A 3-dimensional histology computer model of malignant melanoma and its implications for digital pathology.
Kurz, Alexander; Krahl, Dieter; Kutzner, Heinz; Barnhill, Raymond; Perasole, Antonio; Figueras, Maria Teresa Fernandez; Ferrara, Gerardo; Braun, Stephan A; Starz, Hans; Llamas-Velasco, Mar; Utikal, Jochen Sven; Fröhling, Stefan; von Kalle, Christof; Kather, Jakob Nikolas; Schneider, Lucas; Brinker, Titus J.
Afiliação
  • Kurz A; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Krahl D; Dres. Krahl Dermatopathology, Heidelberg, Germany.
  • Kutzner H; Dermatopathology Friedrichshafen, Friedrichshafen, Germany.
  • Barnhill R; Departments of Pathology and Translational Research, Institut Curie, Paris, France.
  • Perasole A; Division of Histopathology, Cerba Healthcare S.r.l. Rete Diagnostica Italiana, Limena, Italy.
  • Figueras MTF; University General Hospital of Catalonia, Grupo Quironsalud, International University of Catalonia, Sant Cugat del Vallés, Barcelona, Spain.
  • Ferrara G; Anatomic Pathology and Cytopathology Unit Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale, Naples, Italy.
  • Braun SA; Department of Dermatology, University of Münster, Münster, Germany; Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
  • Starz H; Dermpath München, Munich, Germany.
  • Llamas-Velasco M; Department of Dermatology, University Hospital La Princesa, Madrid, Spain.
  • Utikal JS; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim,
  • Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • von Kalle C; Department of Clinical-Translational Sciences, Berlin Institute of Health (BIH), Charité University Medicine, Berlin, Germany.
  • Kather JN; Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany.
  • Schneider L; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brinker TJ; Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: titus.brinker@dkfz.de.
Eur J Cancer ; 193: 113294, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37690178
ABSTRACT

BACKGROUND:

Historically, cancer diagnoses have been made by pathologists using two-dimensional histological slides. However, with the advent of digital pathology and artificial intelligence, slides are being digitised, providing new opportunities to integrate their information. Since nature is 3-dimensional (3D), it seems intuitive to digitally reassemble the 3D structure for diagnosis.

OBJECTIVE:

To develop the first human-3D-melanoma-histology-model with full data and code availability. Further, to evaluate the 3D-simulation together with experienced pathologists in the field and discuss the implications of digital 3D-models for the future of digital pathology.

METHODS:

A malignant melanoma of the skin was digitised via 3 µm cuts by a slide scanner; an open-source software was then leveraged to construct the 3D model. A total of nine pathologists from four different countries with at least 10 years of experience in the histologic diagnosis of melanoma tested the model and discussed their experiences as well as implications for future pathology.

RESULTS:

We successfully constructed and tested the first 3D-model of human melanoma. Based on testing, 88.9% of pathologists believe that the technology is likely to enter routine pathology within the next 10 years; advantages include a better reflectance of anatomy, 3D assessment of symmetry and the opportunity to simultaneously evaluate different tissue levels at the same time; limitations include the high consumption of tissue and a yet inferior resolution due to computational limitations.

CONCLUSIONS:

3D-histology-models are promising for digital pathology of cancer and melanoma specifically, however, there are yet limitations which need to be carefully addressed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha